Low T8 antigen density on lymphocytes in active multiple sclerosis
- PMID: 6236742
- DOI: 10.1002/ana.410160214
Low T8 antigen density on lymphocytes in active multiple sclerosis
Abstract
The median fluorescence intensity of peripheral blood T8+ (T-suppressor/cytotoxic) cells in patients with active (relapsing or progressive) or stable multiple sclerosis (MS) and in control subjects was determined with a fluorescence-activated cell sorter using an indirect immunofluorescence assay. Median fluorescence intensity was significantly lower in patients with active MS than in controls. No differences in median fluorescence intensity were found between patients with stable MS and controls. Analysis of T8+ cells that had been modulated in vitro with OKT8 indicated that the resultant reduction in the median T8 antigen density per cell resulted in fewer T8+ cells being enumerated when the fluorescence-activated cell sorter was used than when a fluorescence microscope was used. Reduced median T8 antigen density on cells as found in active MS may contribute to the apparent underrepresentation of circulating T-suppressor cells in such patients and may be associated with reduced suppressor cell function.
Similar articles
-
Activated suppressor cell dysfunction in progressive multiple sclerosis.J Immunol. 1986 Jul 1;137(1):137-41. J Immunol. 1986. PMID: 2940299
-
Defective suppressor cell function mediated by T8+ cell lines from patients with progressive multiple sclerosis.J Immunol. 1986 Dec 1;137(11):3436-9. J Immunol. 1986. PMID: 2946761
-
Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.N Engl J Med. 1987 Jan 8;316(2):67-72. doi: 10.1056/NEJM198701083160202. N Engl J Med. 1987. PMID: 2946956
-
Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.N Engl J Med. 1980 Jul 17;303(3):125-9. doi: 10.1056/NEJM198007173030303. N Engl J Med. 1980. PMID: 6446039
-
A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis.Ann Neurol. 1984 Mar;15(3):250-6. doi: 10.1002/ana.410150308. Ann Neurol. 1984. PMID: 6232891
Cited by
-
Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.J Clin Invest. 1997 Jun 1;99(11):2664-71. doi: 10.1172/JCI119455. J Clin Invest. 1997. PMID: 9169496 Free PMC article.
-
Cerebrospinal fluid lymphocyte subpopulations in multiple sclerosis.Ital J Neurol Sci. 1986 Feb;7(1):101-5. doi: 10.1007/BF02230426. Ital J Neurol Sci. 1986. PMID: 3957623
-
Immunomodulatory activity of interferon-beta.Ann Clin Transl Neurol. 2014 Aug;1(8):622-31. doi: 10.1002/acn3.84. Epub 2014 Jul 23. Ann Clin Transl Neurol. 2014. PMID: 25356432 Free PMC article. Review.
-
Headache in relapse and remission phases of multiple sclerosis: A case-control study.Iran J Neurol. 2016 Jan 5;15(1):1-8. Iran J Neurol. 2016. PMID: 27141270 Free PMC article.
-
Reduction of immunoglobulin G secretion in vitro following long term lymphoblastoid interferon (Wellferon) treatment in multiple sclerosis patients.Clin Exp Immunol. 1987 Jan;67(1):66-75. Clin Exp Immunol. 1987. PMID: 2957131 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical